Seongkweon Hong Selected Research

Heart Arrest (Cardiac Arrest)

1/2022	Effect of therapeutic hypothermia against renal injury in a rat model of asphyxial cardiac arrest: Α focus on the survival rate, pathophysiology and antioxidant enzymes.
10/2021	Therapeutic Effects of Risperidone against Spinal Cord Injury in a Rat Model of Asphyxial Cardiac Arrest: A Focus on Body Temperature, Paraplegia, Motor Neuron Damage, and Neuroinflammation.
1/2020	Therapeutic Hypothermia Improves Hind Limb Motor Outcome and Attenuates Oxidative Stress and Neuronal Damage in the Lumbar Spinal Cord Following Cardiac Arrest.
7/2019	Therapeutic hypothermia attenuates paraplegia and neuronal damage in the lumbar spinal cord in a rat model of asphyxial cardiac arrest.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seongkweon Hong Research Topics

Disease

9	Ischemia 10/2021 - 09/2015
6	Transient Ischemic Attack 06/2017 - 09/2015
5	Brain Ischemia (Cerebral Ischemia) 12/2017 - 10/2015
4	Heart Arrest (Cardiac Arrest) 01/2022 - 07/2019
3	Hypothermia 01/2022 - 07/2019
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2021 - 07/2019
2	Inflammation (Inflammations) 10/2021 - 12/2015
2	Paraplegia (Spastic Paraplegia) 10/2021 - 07/2019
2	Gliosis 08/2017 - 11/2015
1	Paralysis (Palsy) 10/2021
1	Neuroinflammatory Diseases 10/2021
1	Memory Disorders (Memory Loss) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017
1	Ischemic Stroke 12/2015
1	Reperfusion Injury 11/2015
1	Major Depressive Disorder (Major Depressive Disorders) 11/2015
1	Myocardial Infarction 08/2015
1	Central Nervous System Diseases (CNS Diseases) 08/2015

Drug/Important Bio-Agent (IBA)

6	salicylhydroxamic acid (SHAM)IBA 01/2020 - 09/2015
4	Neuroprotective AgentsIBA 12/2017 - 12/2015
2	EnzymesIBA 01/2022 - 11/2015
2	Superoxide Dismutase-1IBA 01/2020 - 08/2017
2	Glial Fibrillary Acidic ProteinIBA 08/2017 - 11/2015
2	CalciumIBA 08/2017 - 11/2015
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2015
2	Interleukin-13IBA 02/2016 - 09/2015
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	AntioxidantsIBA 01/2022
1	CreatinineIBA 01/2022
1	NitrogenIBA 01/2022
1	Therapeutic UsesIBA 10/2021
1	Antipsychotic Agents (Antipsychotics)IBA 10/2021
1	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2021
1	CatalaseIBA 01/2020
1	8-hydroxyguanineIBA 01/2020
1	Glutathione PeroxidaseIBA 01/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Scopolamine (Hyoscine)FDA Link 01/2018
1	Ethanol (Ethyl Alcohol)IBA 12/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2017
1	Superoxide DismutaseIBA 08/2017
1	Calbindin 1IBA 06/2017
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2017
1	NMDA receptor A1IBA 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017
1	Fenofibrate (CiL)FDA LinkGeneric 02/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2015
1	Lacosamide FDA Link 12/2015
1	EndotoxinsIBA 12/2015
1	ExotoxinsIBA 12/2015
1	Serotonin (5 Hydroxytryptamine)IBA 11/2015
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 11/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2015
1	glucokinase regulatory proteinIBA 10/2015
1	GlucokinaseIBA 10/2015
1	Biological ProductsIBA 10/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015
1	Interleukin-4 (Interleukin 4)IBA 09/2015
1	CytokinesIBA 09/2015
1	InterleukinsIBA 09/2015
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 08/2015
1	fluoro jadeIBA 08/2015
1	cresyl violetIBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015

Therapy/Procedure

3	Induced Hypothermia 01/2022 - 07/2019
2	Cardiopulmonary Resuscitation (CPR) 10/2021 - 07/2019
1	Resuscitation 01/2020
1	Ischemic Postconditioning 11/2015